Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2016
Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors
Amy L Sherborne, Vincent Lavergne, Katharine Yu, et al.
Developmental Cell
|
April 23, 2021
Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease
Bo Zhang, M Yvonne Kim, GiNell Elliot, et al.
Neuro-Oncology
|
April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas
Yao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Cancer Cell
|
September 17, 2015
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors
Tali Mazor, Aleksandr Pankov, Brett E Johnson, et al.
Acta Neuropathologica
|
March 1, 2015
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
Hinke F van Thuijl, Tali Mazor, Brett E Johnson, et al.
NPJ Precision Oncology
|
October 6, 2022
MatchMiner: an open-source platform for cancer precision medicine
Harry Klein, Tali Mazor, Ethan Siegel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>
Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Science (New York, N.Y.)
|
December 17, 2013
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Brett E Johnson, Tali Mazor, Chibo Hong, et al.
Nature Communications
|
July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer
Suzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
JCO Precision Oncology
|
September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors
Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 30, 2016
Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors
Amy L Sherborne, Vincent Lavergne, Katharine Yu, et al.
Developmental Cell
|
April 23, 2021
Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease
Bo Zhang, M Yvonne Kim, GiNell Elliot, et al.
Neuro-Oncology
|
April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas
Yao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Cancer Cell
|
September 17, 2015
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors
Tali Mazor, Aleksandr Pankov, Brett E Johnson, et al.
Acta Neuropathologica
|
March 1, 2015
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
Hinke F van Thuijl, Tali Mazor, Brett E Johnson, et al.
NPJ Precision Oncology
|
October 6, 2022
MatchMiner: an open-source platform for cancer precision medicine
Harry Klein, Tali Mazor, Ethan Siegel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>
Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Science (New York, N.Y.)
|
December 17, 2013
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Brett E Johnson, Tali Mazor, Chibo Hong, et al.
Nature Communications
|
July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer
Suzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
JCO Precision Oncology
|
September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors
Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
Page
of 4